Chang-Min. Lee, et.al., IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses., Nature communications, 2016, 7

http://rdf.ncbi.nlm.nih.gov/pubmed/27629921

Chang-Min. Lee, et.al., IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses., Nature communications, 2016, 7

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased lung apoptosis_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0030002B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• increased lung apoptosis_Il13ra2<tm1Gru>/Il13ra2<tm1Gru>
  http://metadb.riken.jp/0030002B6CgIl13ra2tm1GruIl13ra2tm1GruIl13ra2tm1GruIl13ra2tm1Gru
• increased interleukin-13 secretion_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0008672B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• increased susceptibility to injury_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0005165B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• increased eosinophil cell number_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0005011B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• increased interleukin-4 secretion_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0008699B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• decreased transforming growth factor level_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0008838B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• pulmonary fibrosis_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>,Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
  http://metadb.riken.jp/0006050IC57BL6C57BL6JC57BL6NCBATmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTgScgb1a1rtTAtetOIl131Eli0Tmem219tm1KOMPVlcgTgScgb1a1rtTAtetOIl131Eli
• abnormal susceptibility to injury induced morbidity/mortality_Il13ra2<tm1Gru>/Il13ra2<tm1Gru>
  http://metadb.riken.jp/0020344B6CgIl13ra2tm1GruIl13ra2tm1GruIl13ra2tm1GruIl13ra2tm1Gru
• abnormal susceptibility to injury induced morbidity/mortality_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0020344B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• decreased metastatic potential_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0001273B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• increased IgE level_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0002497B6JB6NTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTmem219tm1KOMPVlcg
• increased susceptibility to injury_Il13ra2<tm1Gru>/Il13ra2<tm1Gru>
  http://metadb.riken.jp/0005165B6CgIl13ra2tm1GruIl13ra2tm1GruIl13ra2tm1GruIl13ra2tm1Gru
• lung inflammation_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>,Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
  http://metadb.riken.jp/0001861IC57BL6C57BL6JC57BL6NCBATmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTgScgb1a1rtTAtetOIl131Eli0Tmem219tm1KOMPVlcgTgScgb1a1rtTAtetOIl131Eli
• increased transforming growth factor level_Tmem219<tm1(KOMP)Vlcg>/Tmem219<tm1(KOMP)Vlcg>,Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
  http://metadb.riken.jp/0008837IC57BL6C57BL6JC57BL6NCBATmem219tm1KOMPVlcgTmem219tm1KOMPVlcgTgScgb1a1rtTAtetOIl131Eli0Tmem219tm1KOMPVlcgTgScgb1a1rtTAtetOIl131Eli